Analyst Price Targets — CRLBF
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 20, 2022 8:37 am | — | Cowen & Co. | $2.50 | $2.23 | Benzinga | Cowen & Co. Downgrades Cresco Labs to Market Perform, Lowers Price Target to $2.5 |
| December 2, 2022 2:32 pm | Gerald Pascarelli | Wedbush | $8.50 | $3.80 | Benzinga | Wedbush Initiates Coverage On Cresco Labs, Curaleaf Holdings With Outperform Ratings |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CRLBF

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended June 30th, 2026 on Thursday, August 6, 2026 before the market opens. The Company will host a conference…

The cannabis industry continues evolving as operators focus on profitability, stronger balance sheets, and strategic expansion. At the same time, federal cannabis reform discussions have improved investor sentiment. Many companies are also positioning themselves for future regulatory changes. As a result, investors are paying closer attention to established multi-state operators with recognizable brands and…

The cannabis industry continues to evolve across the United States. Several operators are expanding their retail footprints while improving profitability. At the same time, investors are watching for regulatory changes that could support future growth. As a result, leading multi-state operators remain popular among cannabis-focused investors.

CRLBF is down 28.5% YTD as revenue pressure and competition persist, but retail expansion and improving estimates could shape its next move.

CHICAGO--(BUSINESS WIRE)--Access to commercial bank financing enhances financial flexibility and supports Cresco Labs' disciplined growth and consolidation strategy.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CRLBF.
Senate Trading
No Senate trades found for CRLBF.
U.S. House Trading
No House trades found for CRLBF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
